Medicared For All Logo

Zurab Davili in Geneva, Ohio

Home Ohio Geneva

Zurab Davili has Urology as his primary medical specialty. Their primary office is: 890 W Main St in Geneva, Ohio. There are 2 additional office locations for Zurab Davili that can be viewed towards the end of their profile.

They're a part of the: Drs Levine Reigle And Schneider Inc medical group which has around 4 members. You can call their office at 440-753-0018 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Zurab Davili Office Phone and Directions

Zurab Davili
Drs Levine Reigle And Schneider Inc
890 W Main St
Geneva, Ohio 44041
440-753-0018


Patient Ratings
Please rate your experience with Zurab Davili below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 440-753-0018


Enter a starting address:


Healthcare Info for Zurab Davili

Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Zurab Davili is listed as: Urology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 7012156250
NPI #: 1831391366
NPI Created On: 06/05/2007
NPI Last Updated Listed as: 07/23/2013
Primary Taxonomy Code: 208600000X
License Number:
57.011779
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Ambetter
  • MOLINA HEALTHCARE OF OHIO
  • Humana
  • Oscar Insurance Corporation of Ohio
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Russian.


Services and Procedures include:

  1. Shock wave crushing of kidney stones
  2. Ultrasound measurement of bladder capacity after voiding
  3. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
  4. Insertion of stent in urinary duct (ureter) using an endoscope
  5. Crushing of stone in urinary duct (ureter) with stent using an endoscope
  6. Ultrasound behind abdominal cavity
  7. Manual urinalysis test with examination using microscope
  8. New patient office or other outpatient visit, typically 30 minutes
  9. New patient office or other outpatient visit, typically 45 minutes
  10. Established patient office or other outpatient visit, typically 5 minutes
  11. Established patient office or other outpatient visit, typically 10 minutes
  12. Established patient office or other outpatient visit, typically 15 minutes
  13. Established patient office or other outpatient, visit typically 25 minutes
  14. Established patient office or other outpatient, visit typically 40 minutes
  15. Initial hospital inpatient care, typically 50 minutes per day
  16. Initial hospital inpatient care, typically 70 minutes per day
  17. Subsequent hospital inpatient care, typically 15 minutes per day
  18. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 777475027

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Urology Endocrinology Men's Health

Name of Drug #1: Natesto

Open Associated Drug #1: 42667-5511-1


Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788110277

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788110279

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794332273

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ENDOCRINOLOGY

Name of Drug #1: LUPRON DEPOT

Open Associated Drug #1: 0074-3346-03


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 826676281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: UROTHELIAL CANCER

Name of Drug #1: JELMYTO

Open Associated Drug #1: 72493-103-03


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 826686975

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: UROTHELIAL CANCER

Name of Drug #1: JELMYTO

Open Associated Drug #1: 72493-103-03


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 836491733

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Prostate Cancer

Name of Drug #1: ELIGARD

Open Associated Drug #1: 62935-753-75


Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Crawford II, Impact of Late Dosing on T Suppression with 2 LA Formulations

Record ID:: 836491737

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Prostate Cancer

Name of Drug #1: ELIGARD

Open Associated Drug #1: 62935-753-75


Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Eligard Powerful Testosterone Suppression Leave Behind

Record ID:: 836491741

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Prostate Cancer

Name of Drug #1: ELIGARD

Open Associated Drug #1: 62935-753-75


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 836491745

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Prostate Cancer

Name of Drug #1: ELIGARD

Open Associated Drug #1: 62935-753-75


Additional Office Locations

1. Drs Levine Reigle And Schneider Inc
36001 Euclid Ave
Willoughby, OH 44094
Suite C14
Group Members: 4

Phone: 440-753-0018

Enter a starting address:


2. Drs Levine Reigle And Schneider Inc
6803 Mayfield Rd
Mayfield Heights, OH 44124
Suite 418
Group Members: 4

Phone: 440-753-0018

Enter a starting address:


Urology Professionals in Geneva

890 W Main St
Geneva, OH
Drs Levine Reigle And Schneider Inc

Providers in Drs Levine Reigle And Schneider Inc

1.Zurab Davili

890 W Main St
Geneva Oh 44041-1237
Drs Levine Reigle And Schneider Inc
Urology

2.Zurab Davili

36001 Euclid Ave
Willoughby Oh 44094-4643
Drs Levine Reigle And Schneider Inc
Urology

3.Zurab Davili

6803 Mayfield Rd
Mayfield Heights Oh 44124-2214
Drs Levine Reigle And Schneider Inc
Urology

4.Frederic Levine Md

36001 Euclid Ave
Willoughby Oh 44094-4643
Drs Levine Reigle And Schneider Inc
Urology

5.Melissa Reigle Md

36001 Euclid Ave
Willoughby Oh 44094-4643
Drs Levine Reigle And Schneider Inc
Urology

6.Kurt Schneider Md

890 W Main St
Geneva Oh 44041-1237
Drs Levine Reigle And Schneider Inc
Urology

View all 4 members of Drs Levine Reigle And Schneider Inc medical group